ABVC BioPharma, Inc.

ECOC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Mar 14, 2024 CURRENT REPORT
10-K Mar 13, 2024 ANNUAL REPORT
8-K/A Feb 29, 2024 AMENDMENT NO.1 TO FORM 8K
8-K/A Feb 29, 2024 CURRENT REPORT
S-1/A Feb 16, 2024 AMENDMENT NO. 2 TO FORM S-1
CORRESP Feb 16, 2024
SC 13G/A Feb 13, 2024
UPLOAD Feb 13, 2024
S-1/A Feb 9, 2024 AMENDMENT NO. 1 TO FORM S-1
CORRESP Feb 9, 2024
8-K Feb 8, 2024 CURRENT REPORT
8-K/A Jan 26, 2024 AMENDMENT NO. 1 TO FORM 8-K
UPLOAD Jan 22, 2024
8-K/A Jan 17, 2024 AMENDMENT NO. 1 TO FORM 8-K
8-K Jan 17, 2024 CURRENT REPORT
8-K Jan 17, 2024 CURRENT REPORT
S-1 Jan 12, 2024 REGISTRATION STATEMENT
DEF 14A Dec 29, 2023 PROXY STATEMENT
PRE 14A Dec 15, 2023 PROXY STATEMENT
8-K Nov 20, 2023 CURRENT REPORT
424B4 Nov 17, 2023 PROSPECTUS SUPPLEMENT
424B4 Nov 17, 2023 PROSPECTUS SUPPLEMENT
424B3 Nov 17, 2023 PROSPECTUS SUPPLEMENT
8-K Nov 16, 2023 CURRENT REPORT
8-K Nov 15, 2023 CURRENT REPORT
← Newer Page 6 of 32 · 793 filings Older →